We found that Kallikrein-5 is necessary for PAR-2-mediated IL-8 release, YAP1-TAZ/TEAD activation, and matriptase-mediated oral squamous cell carcinoma migration. The gene discussed is F2RL1; the disease is oral cavity squamous cell carcinoma.